Avaana Capital leads $3.8 mn seed round in biotech startup GreenGrahi

The funding will be used to build one of India's largest facilities capable of processing 150 tons of feedstock daily and also expand the scientific team and enter global markets

Avaana Capital
Shruti Srivastava, investment director at Avaana Capital, said GreenGrahi’s proprietary insect biotechnology and bioprocessing platform enables the production of high-performance, cost-efficient ingredients at scale.
BS Reporter Bengaluru
2 min read Last Updated : Apr 24 2025 | 10:28 PM IST
Avaana Capital has led a Rs 32 crore ($3.8 million) seed funding round in GreenGrahi, a biotech startup developing alternatives to traditional animal feed and chemical agricultural inputs using insect biotechnology.
 
The round also saw participation from existing investors Huddle Ventures, Campus Fund, and Blume Founders Fund. It also included leading angel investors such as Nitin Sharma (Nexus Ventures), Anchit Gupta (Samara Capital), David Chen (Equilibrium Capital), and Sameer Brij Verma (Northpoint Capital).
 
Shruti Srivastava, investment director at Avaana Capital, said GreenGrahi’s proprietary insect biotechnology and bioprocessing platform enables the production of high-performance, cost-efficient ingredients at scale. “This is helping build resilient food supply chains for global food security through science-backed, market-ready solutions.”
 
The Rs 32 crore raise will be used to build India’s largest Black Soldier Fly (BSF) bio-factory, capable of processing 150 tons of feedstock daily. The company will also expand its scientific team and enter global markets, including the US, UK, and EU.
 
“The demand is real, and India needed a bold, full-stack operator to build for both local and global markets,” said Ishaan Khosla, partner at Huddle Ventures.
 
Founded by Shivali Sugand and Siddharth Sharma, GreenGrahi is developing a differentiated insect biotechnology platform powered by the Black Soldier Fly (BSF) and its unique microbiome. The company produces high-performance insect proteins, functional oils, and hydrolysates tailored for aquaculture, poultry, and pets. These are designed to deliver superior nutrition, better digestibility, and greater price stability compared to conventional inputs like fishmeal and soya. Alongside, GreenGrahi has built a new generation of biological agri-inputs—including biofertilisers, biostimulants, and biopesticides—that help improve soil health, boost crop resilience and yield. This helps reduce the need for chemical fertilisers and pesticides.
 
“As wild fish stocks continue to decline and protein demand rises, the pressure on aquafeed and livestock inputs is only going to grow,” said Siddharth Sharma, co-founder of GreenGrahi. “We’re building a platform that makes high-quality, science-driven feed and agri-inputs accessible, affordable, and scalable for global markets.”
 
In agriculture, the company said its biological products have demonstrated 25–30 per cent yield improvements, better soil nutrient retention, and reduced pest attacks. This has helped deliver higher farmer incomes while helping offset the environmental costs of synthetic inputs.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :fundingsbiotechGlobal MarketsBiotechnology

Next Story